Next Article in Journal
Alteration of N-glycans and Expression of Their Related Glycogenes in the Epithelial-Mesenchymal Transition of HCV29 Bladder Epithelial Cells
Next Article in Special Issue
Resveratrol Inhibits Trophoblast Apoptosis through Oxidative Stress in Preeclampsia-Model Rats
Previous Article in Journal
Chemical Composition, Antibacterial and Antioxidant Activities of Six Essentials Oils from the Alliaceae Family
Previous Article in Special Issue
Resveratrol Trimers from Seed Cake of Paeonia rockii
Article Menu

Export Article

Open AccessArticle
Molecules 2014, 19(12), 20054-20072;

Resveratrol Modulates the Topoisomerase Inhibitory Potential of Doxorubicin in Human Colon Carcinoma Cells

Department of Food Chemistry and Toxicology, University of Vienna, Währinger Str. 38, 1090 Wien, Austria
Author to whom correspondence should be addressed.
Received: 3 September 2014 / Revised: 24 November 2014 / Accepted: 25 November 2014 / Published: 1 December 2014
(This article belongs to the Special Issue Resveratrol)
Full-Text   |   PDF [634 KB, uploaded 1 December 2014]   |  


Resveratrol (RSV) is currently being widely discussed as potentially useful for anticancer therapy in combination with classical chemotherapeutics, e.g., the topoisomerase II (TOP II) poison doxorubicin (DOX). However, there is still a lack of knowledge of possible interference at the target enzyme, especially since RSV itself has recently been described to act as a TOP poison. We therefore sought to address the question whether RSV affects DOX-induced genotoxic and cytotoxic effects with special emphasis on TOP II in HT-29 colon carcinoma cells. RSV was found to counteract DOX-induced formation of DNA-TOP-intermediates at ≥100 µM for TOP IIα and at 250 µM for TOP IIβ. As a consequence, RSV modulated the DNA-strand breaking potential of DOX by mediating protective effects with an apparent maximum at 100 µM. At higher concentration ranges (≥200 µM) RSV diminished the intracellular concentrations of DOX. Nevertheless, the presence of RSV slightly enhanced the cytotoxic effects of DOX after 1.5 h and 24 h of incubation. Taken together, at least in cell culture RSV was found to affect the TOP-poisoning potential of DOX and to modulate its cytotoxic effectiveness. Thus, further studies are needed to clarify the impact of RSV on the therapeutic effectiveness of DOX under in vivo conditions. View Full-Text
Keywords: resveratrol; doxorubicin; colon cancer; topoisomerase resveratrol; doxorubicin; colon cancer; topoisomerase

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Schroeter, A.; Marko, D. Resveratrol Modulates the Topoisomerase Inhibitory Potential of Doxorubicin in Human Colon Carcinoma Cells. Molecules 2014, 19, 20054-20072.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top